Dow Jones

39 375,87

0,17%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Bellevue Life Sciences Acquisition Corporation (BLACU)
Bellevue Life Sciences Acquisition Corporation (BLACU) Actualités

BLACU

Bellevue Life Sciences A... (BLACU)

Bellevue Life Sciences Acquisition Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:BLACU

Date	Heure	Source	Titre	Symbole	Société
21/02/2024	22h20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
08/02/2024	22h20	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
05/02/2024	19h48	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
16/11/2023	23h00	PR Newswire (US)	OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp.	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
16/11/2023	22h37	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
07/11/2023	22h20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
20/10/2023	22h20	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
10/10/2023	23h00	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
11/07/2023	22h45	PR Newswire (US)	Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business Combination	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
14/06/2023	23h01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
22/05/2023	22h35	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
16/05/2023	14h01	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
31/03/2023	22h20	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
27/03/2023	22h10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
14/03/2023	21h05	PR Newswire (US)	Bellevue Life Sciences Acquisition Corp. Announces Separate Trading of its Shares of Common Stock, Warrants and Rights Commencing March 17, 2023	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
21/02/2023	22h05	PR Newswire (US)	Bellevue Life Sciences Acquisition Corp. Announces Closing of Full Over-allotment Option	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation
14/02/2023	22h05	PR Newswire (US)	Bellevue Life Sciences Acquisition Corp. Announces Closing of $60 Million Initial Public Offering	NASDAQ:BLACU	Bellevue Life Sciences Acquisition Corporation